SG Americas Securities
ACIU icon

SG Americas Securities’s AC Immune ACIU Stock Holding History

SG Americas Securities’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25K Buy
+10,327
New +$28.5K ﹤0.01% 3250

Other funds holding ACIU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
AC
AXQ Capital Jersey City, New Jersey $920M AUM 18.71% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BCV
Banque Cantonale Vaudoise Lausanne, Switzerland $722M AUM 30.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

SG Americas Securities's ACIU Position: Q2 2026 in Review

SG Americas Securities opened a new position in AC Immune (ACIU) in Q2 2026: 10,327 shares worth $25K. The stake represents ﹤0.01% of the portfolio and ranks #3250 among its holdings.

20 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • SG Americas Securities held 10,327 shares of AC Immune worth $25K as of Q2 2026.
  • AC Immune was a new SG Americas Securities position in Q2 2026.
  • AC Immune made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3250 holding.
  • 20 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.